Healthcare Beyond CRISPR: Recent Technology Advances in Rewriting DNA

Emerging Tools Reshaping the Future of Gene Editing

INDUSTRY
Healthcare

RELEASE DATE
22-Oct-2025
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
DB4D-01-00-00-00
SKU
HC_2025_34084
Yes
SHARE

Beyond CRISPR: Recent Technology Advances in Rewriting DNA
Published on: 22-Oct-2025 | SKU: HC_2025_34084

Need more details?
$4,950.00
DownloadLink
Need more details?

This study highlights advancements such as prime editing, base editing, bridge RNA, SeekRNA, and gene writing platforms, as it examines the emerging field of next-generation gene editing technologies beyond CRISPR/Cas systems. These tools are revolutionary for therapeutic development, precision medicine, and functional genomics because they provide increased editing capabilities, decreased off-target effects, and improved precision. To improve accuracy and efficiency in genome engineering, the study highlights the use of artificial intelligence (AI) and machine learning for guide RNA optimization, off-target prediction, and scalable clinical translation. The collaborative innovation ecosystem is mapped by examining key stakeholders, including academic consortia, large pharmaceutical companies, biotech start-ups, and companies that provide AI-driven editing solutions. Additionally, to evaluate commercialization readiness, global funding trends, investment patterns, and regulatory environments in North America, Europe, Asia-Pacific, and emerging regions are examined. The study highlights how disruptive tools are changing the future of genetic medicine and biotechnology by spotting growth prospects and strategic partnerships.

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8

The Impact of the Top 3 Strategic Imperatives on the Beyond CRISPR Rewriting DNA Space

Growth Opportunities Fuel the Growth Pipeline Engine

Research Methodology

Scope of Analysis

Segmentation

Growth Drivers

Growth Restraints

CRISPR—Clustered Regularly Interspaced Short Palindromic Repeats

Pros and Cons of CRISPR Gene Editing

Prime Editing—Expanding Accuracy and Versatility in Gene Editing

Recent Innovations in Prime Editing

Bridge RNA—The Third Generation of Genetic Engineering

SeekRNA—A New Pathway for Accurate Gene Editing

Epigenome Editing

Base Editing: Unlocking Single-Nucleotide Precision

Recent Innovations in Base Editing

Gene Writing—A New Blueprint for Genome Engineering

Recent Innovations in Gene Writing

AI and Machine Learning AI/ML in Gene Editing

Emerging Trends in Gene Editing and AI

Stakeholders Developing Gene Editing Technologies

Key Collaborations in Gene Editing Technologies—Global 2023–2025

Snapshot of Industry Funding—Global 2023–2025

Snapshot of Academia Funding—Global 2023–2025

Regional Trends in Gene Editing—Developments and Adoption

Growth Opportunity 1: AI-Driven Guide Design and Off-Target Prediction in Gene Editing

Growth Opportunity 2: Next-Generation Gene Editing Tools

Growth Opportunity 3: Large DNA Integration and Rewriting

TRL: Explanation

Benefits and Impacts of Growth Opportunities

Next Steps

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related In Vitro Diagnostics (IVD) research

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

25 Aug 2026   |   Global   |   Technology Research

Breakthrough Innovations in Point-of-Care Diagnostics

This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, ...

21 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...

07 Aug 2026   |   Global   |   Customer Research

Laboratory Product Purchasing Trends, United States and Europe, 2025–2026

Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The surv...

21 Jul 2026   |   Global   |   Market Research

Point-of-Care Testing Market, Global, 2024–2031

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This study highlights advancements such as prime editing, base editing, bridge RNA, SeekRNA, and gene writing platforms, as it examines the emerging field of next-generation gene editing technologies beyond CRISPR/Cas systems. These tools are revolutionary for therapeutic development, precision medicine, and functional genomics because they provide increased editing capabilities, decreased off-target effects, and improved precision. To improve accuracy and efficiency in genome engineering, the study highlights the use of artificial intelligence (AI) and machine learning for guide RNA optimization, off-target prediction, and scalable clinical translation. The collaborative innovation ecosystem is mapped by examining key stakeholders, including academic consortia, large pharmaceutical companies, biotech start-ups, and companies that provide AI-driven editing solutions. Additionally, to evaluate commercialization readiness, global funding trends, investment patterns, and regulatory environments in North America, Europe, Asia-Pacific, and emerging regions are examined. The study highlights how disruptive tools are changing the future of genetic medicine and biotechnology by spotting growth prospects and strategic partnerships.
More Information
Deliverable Type Technology Research
Industries Healthcare
No Index No
Is Prebook No
Podcast No
Predecessor None
WIP Number DB4D-01-00-00-00

Beyond CRISPR: Recent Technology Advances in Rewriting DNA

$4,950.00
In stock
SKU
HC_2025_34084